Logo image of NAII

NATURAL ALTERNATIVES INTL (NAII) Stock Fundamental Analysis

NASDAQ:NAII - Nasdaq - US6388423021 - Common Stock - Currency: USD

3.85  -0.01 (-0.26%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NAII. NAII was compared to 35 industry peers in the Personal Care Products industry. NAII has a bad profitability rating. Also its financial health evaluation is rather negative. NAII is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

NAII had negative earnings in the past year.
In the past year NAII has reported a negative cash flow from operations.
In multiple years NAII reported negative net income over the last 5 years.
NAII had a positive operating cash flow in 4 of the past 5 years.
NAII Yearly Net Income VS EBIT VS OCF VS FCFNAII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of NAII (-5.31%) is worse than 71.43% of its industry peers.
With a Return On Equity value of -10.75%, NAII perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
ROA -5.31%
ROE -10.75%
ROIC N/A
ROA(3y)1.58%
ROA(5y)2.48%
ROE(3y)2.06%
ROE(5y)3.48%
ROIC(3y)N/A
ROIC(5y)N/A
NAII Yearly ROA, ROE, ROICNAII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

The Gross Margin of NAII (5.72%) is worse than 85.71% of its industry peers.
NAII's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NAII so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.24%
GM growth 5Y-18.78%
NAII Yearly Profit, Operating, Gross MarginsNAII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

3

2. Health

2.1 Basic Checks

NAII does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NAII has been increased compared to 1 year ago.
Compared to 5 years ago, NAII has less shares outstanding
Compared to 1 year ago, NAII has a worse debt to assets ratio.
NAII Yearly Shares OutstandingNAII Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
NAII Yearly Total Debt VS Total AssetsNAII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

NAII has an Altman-Z score of 1.67. This is a bad value and indicates that NAII is not financially healthy and even has some risk of bankruptcy.
NAII has a Altman-Z score of 1.67. This is in the lower half of the industry: NAII underperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that NAII is not too dependend on debt financing.
NAII has a Debt to Equity ratio of 0.14. This is in the better half of the industry: NAII outperforms 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACCN/A
WACC6.72%
NAII Yearly LT Debt VS Equity VS FCFNAII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

NAII has a Current Ratio of 2.51. This indicates that NAII is financially healthy and has no problem in meeting its short term obligations.
NAII has a Current ratio of 2.51. This is in the better half of the industry: NAII outperforms 62.86% of its industry peers.
NAII has a Quick Ratio of 1.35. This is a normal value and indicates that NAII is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.35, NAII is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.35
NAII Yearly Current Assets VS Current LiabilitesNAII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

0

3. Growth

3.1 Past

NAII shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.50%.
Looking at the last year, NAII shows a small growth in Revenue. The Revenue has grown by 4.40% in the last year.
Measured over the past years, NAII shows a decrease in Revenue. The Revenue has been decreasing by -3.83% on average per year.
EPS 1Y (TTM)-146.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.82%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-13.93%
Revenue growth 5Y-3.83%
Sales Q2Q%14.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAII Yearly Revenue VS EstimatesNAII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NAII Yearly EPS VS EstimatesNAII Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 0.5 1 1.5

0

4. Valuation

4.1 Price/Earnings Ratio

NAII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAII Price Earnings VS Forward Price EarningsNAII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAII Per share dataNAII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NAII does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NATURAL ALTERNATIVES INTL

NASDAQ:NAII (8/19/2025, 4:03:15 PM)

3.85

-0.01 (-0.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-08 2025-05-08
Earnings (Next)09-25 2025-09-25
Inst Owners33.49%
Inst Owner Change-0.06%
Ins Owners21.37%
Ins Owner Change0.3%
Market Cap23.79M
Analysts0
Price TargetN/A
Short Float %0.52%
Short Ratio6.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)-1.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS20.3
BVpS12.4
TBVpS12.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.31%
ROE -10.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.72%
FCFM N/A
ROA(3y)1.58%
ROA(5y)2.48%
ROE(3y)2.06%
ROE(5y)3.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.24%
GM growth 5Y-18.78%
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.29%
Cap/Sales 2.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 1.35
Altman-Z 1.67
F-Score4
WACC6.72%
ROIC/WACCN/A
Cap/Depr(3y)339.43%
Cap/Depr(5y)250.14%
Cap/Sales(3y)8.97%
Cap/Sales(5y)6.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-13.93%
Revenue growth 5Y-3.83%
Sales Q2Q%14.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-225.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-101.57%
OCF growth 3YN/A
OCF growth 5YN/A